Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sensile Medical is a Swiss medical technology company focused on drug-delivery devices rather than therapeutics. Founded in 2004 and acquired by Gerresheimer in 2018, the company develops wearable on-body injectors, patch pumps, autoinjectors, and micro-infusion systems for subcutaneous delivery of liquid drugs, primarily in partnership with pharmaceutical and biotech companies. Its core proprietary technology is the SenseCore micro rotary piston pump platform, designed for precise, programmable delivery of small- and large-volume liquid medicines. Sensile operates as Gerresheimer's advanced technologies and development hub in Olten, Switzerland, supporting connected and patient-friendly drug delivery systems. The business is best characterized as a commercial medtech/OEM platform company serving pharma combination-product programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sensile Medical.